^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ALT-801
i
Other names: ALT-801, TCR-IL-2, p53-specific scTCR/IL-2 fusion protein, soluble tumor antigen-specific T cell receptor (TCR) linked to interleukin-2 (IL-2), 264scTCR/IL-2, STAR-Ck, c264scTCR-IL2
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
ImmunityBio
Drug class:
Immunomodulator, IL-2 stimulant, IFNγ stimulant
Related drugs:
4ms
A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer (clinicaltrials.gov)
P1/2, N=12, Terminated, Altor BioScience | N=52 --> 12 | Unknown status --> Terminated; The study was terminated early due to low enrollment.
Enrollment change • Trial termination
|
gemcitabine • ALT-801
6ms
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer (clinicaltrials.gov)
P1/2, N=68, Completed, Altor BioScience | Unknown status --> Completed
Trial completion • Combination therapy • Metastases
|
cisplatin • gemcitabine • ALT-801
Share via
